Novartis enters agreement to acquire Mariana Oncology, …

May 2, 2024 · The acquisition encompasses a robust portfolio of RLT programs spanning lead optimization to early development across a range of solid tumor indications such as breast, …

CouponFollow Extension

$1.75
OFF

Novartis To Buy Mariana Oncology For Up To $1.75 Billion In Boost …

21 hours ago

May 2, 2024 · Novartis agreed to acquire U.S. biotechnology company Mariana Oncology for up to $1.75 billion, in a deal that bolsters its radioligand therapy pipeline and efforts to develop …

morningstar.com

$175
OFF

Mariana Oncology Announces $175 Million Series B Financing

21 hours ago

Sep 7, 2023 · Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, today ann ... Media: …

businesswire.com

FAQs about Novartis enters agreement to acquire Mariana Oncology, … Coupon?

Will Mariana oncology be acquired by Novartis?

Watertown, Mass., May 2, 2024 – Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments. ...

What's new at Mariana oncology?

This journey has brought us to a new name: We are now Mariana Oncology Check back here for the latest on Mariana Oncology. Acquisition of Mariana Oncology brings together two companies at the forefront of novel radiopharmaceutical development, with a total potential value of up to $1.75 billion ...

What happened to Mariana oncology?

WATERTOWN, Mass.-- ( BUSINESS WIRE )--Mariana Oncology Inc., a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat cancers with high unmet need, today announced the closing of an oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion. ...

What is Mariana oncology?

Mariana Oncology is a fully integrated, radiopharmaceutical company pioneering a new standard of care in cancer treatment – targeted peptide-based radioligand therapeutics (RLTs) designed to maximize tumor penetration while minimizing toxicity. ...

Who congratulates Mariana oncology?

Geert-Jan Mulder, Forbion Managing Partner, and Mariana board member commented on today’s news, "Forbion congratulates Mariana Oncology with this great deal that showcases the excitement of its pipeline. ...

Who owns Mariana oncology?

This follows an oversubscribed $175 million Series B financing in Mariana Oncology in September 2023 co-led by Forbion and Deep Track Capital, alongside founding investors Atlas Venture, Access Biotechnology, RA Capital Management and new investors Nextech Invest, Surveyor Capital (a Citadel company) and Eli Lilly and Company. ...